ALPS Advisors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
AC
CS
ALPS Advisors's BLUE Position: Q4 2021 in Review
ALPS Advisors sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 6,395 shares — an estimated $1.58M sold.
ALPS Advisors first reported a position in BLUE in Q1 2015 and held it in 16 quarters. The position peaked at $9.79M in Q4 2019. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.
- ALPS Advisors reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
- ALPS Advisors sold 6,395 bluebird bio shares in Q4 2021, an estimated $1.58M.
- ALPS Advisors first reported a position in bluebird bio in Q1 2015 and held it in 16 quarters.
- ALPS Advisors's bluebird bio position peaked at $9.79M in Q4 2019.
- 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.
Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.